AUPH

Aurinia Pharmaceuticals (AUPH) Stock Price

Closed
AUPH
$15.73
-$0.44(-2.72%)

Content updated: 2026-11-16 16:46:27

Yesterday's Close
$16.17
Today's Open
$15.92
Today's High
$16.09
Today's Low
$15.73
Volume
960.84K shares
52-Week Range
$13.30-$19.99

As of 2026-11-16 16:46:27, Aurinia Pharmaceuticals (AUPH) was quoted at $15.73, a change of -$0.44 (-2.72%) from the previous close. The day's range was $15.73–$16.09, and the 52-week range was $13.30–$19.99.

Past 1W-4.66%Period Low $13.30Period High $18.00
Past 1M-3.85%Period Low $13.30Period High $18.50
Past 3M+4.10%Period Low $13.30Period High $18.50

About Aurinia Pharmaceuticals (AUPH)

Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed for adult individuals suffering from active lupus nephritis. Furthermore, Aurinia maintains a strategic collaboration and licensing agreement with Otsuka Pharmaceutical Co., Ltd. The firm's main corporate office is located in Victoria, Canada.
Ticker / Exchanges
AUPH / NASDAQ
Industry / Sector
Biotechnology / Healthcare
CEO
Kevin C. Tang
Headquarters
Edmonton,AB,CA
Listing Date
2014-09-03

Recent Company Events

  • 2026-07-30
    Earnings Report · ExpectedOn 2026-07-30, the 2026/Q2 earnings report is expected to be released.

Aurinia Pharmaceuticals (AUPH) Derivatives Trading

AUPHTrade
CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

Aurinia Pharmaceuticals (AUPH) Company Financials

Valuation and Shares

Market Cap
--
P/E Ratio (TTM)
--
P/B Ratio
--
Shares Outstanding
--
Float Shares
--
Dividend Yield (TTM)
--

Latest Reported Financials

2026 Q1 Financials

Report Release Date: 2026-05-07

Operating Revenue (Actual)

$77.70M

Same Period Last Year: +24.40%

Earnings per Share (Actual)

$0.25

Same Period Last Year: +56.25%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$134.03M$175.51M$235.13M$283.05M
Net Profit-$108.18M-$78.02M$5.75M$287.20M
Operating Cash Flow-$79.52M-$33.46M$44.38M$135.65M

AUPH FAQ

What is the current stock price of Aurinia Pharmaceuticals (AUPH)?

x
As of 2026-11-16 16:46 (UTC+8), the latest available quote for Aurinia Pharmaceuticals (AUPH) is $15.73 USD, with a change of -$0.44 USD (-2.72%) from the previous trading day's close. Current market status: Closed.

Which exchange is AUPH listed on?

x

How has Aurinia Pharmaceuticals stock performed over the past month?

x

What is the market cap of Aurinia Pharmaceuticals?

x

What are Aurinia Pharmaceuticals's latest financial results?

x

What factors may affect the stock price of Aurinia Pharmaceuticals (AUPH)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.